Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SZC vs SPS for Hyperkalemia in Hemodialysis
NCT06029179Completed
- Sponsor
- Alexandria University
- Start
- Jan 2024
- Primary completion
- Oct 2024
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Randomised, open-label trial of sodium zirconium cyclosilicate in hyperkalemia (2 arms), sponsored by Alexandria University. Primary endpoint: Change in serum potassium at 8 weeks. Started Jan 2024; status: completed.
02
Drugs
sodium zirconium cyclosilicate
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT06029179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06029179.